Abstract:BACKGROUND:The molecular characteristics of human diseases are often represented by a list of genes termed "signature genes". A significant challenge facing this approach is that of reproducibility: signatures developed on a set of patients may fail to perform well on different sets of patients. As diseases are resulted from perturbed cellular functions, irrespective of the particular genes that contribute to the function, it may be more appropriate to characterize diseases based on these perturbed cellular functions. METHODS:We proposed a profile-based approach to characterize a disease using a binary vector whose elements indicate whether a given function is perturbed based on the enrichment analysis of expression data between normal and tumor tissues. Using breast cancer and its four primary clinically relevant subtypes as examples, this approach is evaluated based on the reproducibility, accuracy and resolution of the resulting pathway profiles. RESULTS:Pathway profiles for breast cancer and its subtypes are constructed based on data obtained from microarray and RNA-Seq data sets provided by The Cancer Genome Atlas (TCGA), and an additional microarray data set provided by The European Genome-phenome Archive (EGA). An average reproducibility of 68% is achieved between different data sets (TCGA microarray vs. EGA microarray data) and 67% average reproducibility is achieved between different technologies (TCGA microarray vs. TCGA RNA-Seq data). Among the enriched pathways, 74% of them are known to be associated with breast cancer or other cancers. About 40% of the identified pathways are enriched in all four subtypes, with 4, 2, 4, and 7 pathways enriched only in luminal A, luminal B, triple-negative, and HER2+ subtypes, respectively. Comparison of profiles between subtypes, as well as other diseases, shows that luminal A and luminal B subtypes are more similar to the HER2+ subtype than to the triple-negative subtype, and subtypes of breast cancer are more likely to be closer to each other than to other diseases. CONCLUSIONS:Our results demonstrate that pathway profiles can successfully characterize both common and distinct functional characteristics of four subtypes of breast cancer and other related diseases, with acceptable reproducibility, high accuracy and reasonable resolution.

Biological Pathway Conducting Microarray-Based Cancer Classification

State of the Art on Cancer Classification Problems Based on DNA Microarray Data

Molecular Signature of Cancer at Gene Level or Pathway Level? Case Studies of Colorectal Cancer and Prostate Cancer Microarray Data.

A pathway-based classification method that can improve microarray-based colorectal cancer diagnosis

Cancer classification from the gene expression profiles by Discriminant Kernel-PLS.

Identification, Modeling and Simulation of Key Pathways Underlying Certain Cancers

Towards precise classification of cancers based on robust gene functional expression profiles

Deep-Learning-Based Cancer Profiles Classification Using Gene Expression Data Profile

A Survey of Gene Selection and Classification Techniques Based on Cancer Microarray Data Analysis

Classifying Dna Microarray For Cancer Diagnosis Via Method Based On Complex Networks

Finding disagreement pathway signatures and constructing an ensemble model for cancer classification

[Research on pattern classification methods using gene expression data].

Multiclass cancer diagnosis using tumor gene expression signatures

Classification of human cancer diseases by gene expression profiles

Classification of a DNA Microarray for Diagnosing Cancer Using a Complex Network Based Method.

Functional characterization of breast cancer using pathway profiles.

Proteomics, Pathway Array and Signaling Network-Based Medicine in Cancer

On Gene Selection and Classification for Cancer Microarray Data Using Multi-Step Clustering and Sparse Representation

Identifying Dysregulated Pathways in Cancers from Pathway Interaction Networks

Functional and Embedding Feature Analysis for Pan-Cancer Classification

A Method for Finding Tumor Functional Modules Using DNA Microarray Data